27687042|t|Simvastatin enhances the hippocampal klotho in a rat model of streptozotocin - induced cognitive decline
27687042|a|Brain oxidative status is a crucial factor in the development of sporadic Alzheimer's disease (AD). Klotho, an anti-aging protein, diminishes oxidative stress by the induction of manganese superoxide dismutase (MnSOD). Thus, the substances that increase klotho expression could be considered as a potential treatment for Alzheimer's disease when the oxidative imbalance is present. Statins are suggested to up-regulate klotho expression. We examined the effect of simvastatin (5mg/kg, daily for 3 weeks) on hippocampal klotho and MnSOD expression in the cognitive declined animal model induced by intracerebroventricular (ICV)- streptozotocin (STZ) administration. Cognitive assessment was performed by the Morris Water Maze (MWM) test. The results indicated that mean escape latency and distance were prolonged in the ICV - STZ group compared with the control group. The expression of klotho and MnSOD were also down regulated in the hippocampus. Furthermore, improved spatial performance was observed in simvastatin - treated animals. This effect could be related to increase in oxidative stress tolerance as evidenced by klotho and MnSOD up-regulation. Our current study indicates that klotho upregulation may be a neuroprotective mechanism of simvastatin against cognitive decline in AD.
27687042	0	11	Simvastatin	T109,T121	C0074554
27687042	12	20	enhances	T052	C2349975
27687042	25	36	hippocampal	T023	C0019564
27687042	37	43	klotho	T116,T192	C0667394
27687042	49	52	rat	T015	C0034721
27687042	53	58	model	T050	C0012644
27687042	62	76	streptozotocin	T109,T195	C0038432
27687042	79	86	induced	T169	C0205263
27687042	87	104	cognitive decline	T046	C0234985
27687042	105	110	Brain	T023	C0006104
27687042	111	127	oxidative status	T080	C0449438
27687042	141	147	factor	T169	C1521761
27687042	155	166	development	T169	C1527148
27687042	170	178	sporadic	T079	C0205422
27687042	179	198	Alzheimer's disease	T047	C0002395
27687042	200	202	AD	T047	C0002395
27687042	205	211	Klotho	T116,T192	C0667394
27687042	216	234	anti-aging protein	T116,T123	C0033684
27687042	236	246	diminishes	T081	C0205216
27687042	247	263	oxidative stress	T049	C0242606
27687042	271	280	induction	T169	C0205263
27687042	284	314	manganese superoxide dismutase	T116,T126	C0024708
27687042	316	321	MnSOD	T116,T126	C0024708
27687042	334	344	substances	T167	C0439861
27687042	350	358	increase	T169	C0442805
27687042	359	365	klotho	T116,T192	C0667394
27687042	366	376	expression	T045	C1171362
27687042	412	421	treatment	T061	C0087111
27687042	426	445	Alzheimer's disease	T047	C0002395
27687042	455	474	oxidative imbalance	T049	C0242606
27687042	487	494	Statins	T109,T121	C0360714
27687042	512	523	up-regulate	T044	C0041904
27687042	524	530	klotho	T116,T192	C0667394
27687042	531	541	expression	T045	C1171362
27687042	559	565	effect	T080	C1280500
27687042	569	580	simvastatin	T109,T121	C0074554
27687042	590	595	daily	T079	C0332173
27687042	602	607	weeks	T079	C0439230
27687042	612	623	hippocampal	T023	C0019564
27687042	624	630	klotho	T116,T192	C0667394
27687042	635	640	MnSOD	T116,T126	C0024708
27687042	641	651	expression	T045	C1171362
27687042	659	677	cognitive declined	T046	C0234985
27687042	678	690	animal model	T050	C0012644
27687042	691	698	induced	T169	C0205263
27687042	702	725	intracerebroventricular	T082	C0595818
27687042	727	730	ICV	T082	C0595818
27687042	733	747	streptozotocin	T109,T195	C0038432
27687042	749	752	STZ	T109,T195	C0038432
27687042	754	768	administration	T061	C1533734
27687042	770	790	Cognitive assessment	T060	C0870300
27687042	812	840	Morris Water Maze (MWM) test	T170	C0871098
27687042	869	888	mean escape latency	T081	C0392762
27687042	893	901	distance	T081	C0012751
27687042	907	916	prolonged	T079	C0439590
27687042	924	927	ICV	T082	C0595818
27687042	930	933	STZ	T109,T195	C0038432
27687042	934	939	group	T078	C0441833
27687042	958	971	control group	T096	C0009932
27687042	977	987	expression	T045	C1171362
27687042	991	997	klotho	T116,T192	C0667394
27687042	1002	1007	MnSOD	T116,T126	C0024708
27687042	1018	1032	down regulated	T044	C0013081
27687042	1040	1051	hippocampus	T023	C0019564
27687042	1075	1094	spatial performance	T052	C1882330
27687042	1111	1122	simvastatin	T109,T121	C0074554
27687042	1125	1132	treated	T169	C1522326
27687042	1133	1140	animals	T008	C0003062
27687042	1147	1153	effect	T080	C1280500
27687042	1174	1182	increase	T169	C0442805
27687042	1186	1202	oxidative stress	T049	C0242606
27687042	1203	1212	tolerance	T080	C1704410
27687042	1229	1235	klotho	T116,T192	C0667394
27687042	1240	1245	MnSOD	T116,T126	C0024708
27687042	1246	1259	up-regulation	T044	C0041904
27687042	1294	1300	klotho	T116,T192	C0667394
27687042	1301	1313	upregulation	T044	C0041904
27687042	1323	1348	neuroprotective mechanism	T169	C0441712
27687042	1352	1363	simvastatin	T109,T121	C0074554
27687042	1372	1389	cognitive decline	T046	C0234985
27687042	1393	1395	AD	T047	C0002395